CG Oncology Inc. Common s... (CGON)
CG Oncology Common stock Statistics
Share Statistics
CG Oncology Common stock has 76.23M shares outstanding. The number of shares has increased by 15.29% in one year.
| 76.23M |
| 15.29% |
| 0.92% |
| 95.76% |
| n/a |
| 26 |
| n/a |
Short Selling Information
The latest short interest is 11.56M, so 15.16% of the outstanding shares have been sold short.
| 11.56M |
| 15.16% |
| 16.05% |
| 6.28 |
Valuation Ratios
The PE ratio is -20.36 and the forward PE ratio is -15.66. CG Oncology Common stock's PEG ratio is -0.22.
| -20.36 |
| -15.66 |
| 1573.67 |
| 2.5 |
| 2.44 |
| -22.7 |
| -0.22 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CG Oncology Common stock.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 35.3, with a Debt / Equity ratio of 0.
| 35.3 |
| 35.3 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $10,079.65 |
| $-779,106.19 |
| 113 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -23.7% in the last 52 weeks. The beta is 0.86, so CG Oncology Common stock's price volatility has been higher than the market average.
| 0.86 |
| -23.7% |
| 23.59 |
| 30.3 |
| 56.88 |
| 1,366,539 |
Income Statement
In the last 12 months, CG Oncology Common stock had revenue of 1.14M and earned -88.04M in profits. Earnings per share was -1.41.
| 1.14M |
| 1.14M |
| -114.67M |
| -88.04M |
| -114.63M |
| -114.67M |
| -1.41 |
Balance Sheet
The company has 257.07M in cash and 238K in debt, giving a net cash position of 256.83M.
| 257.07M |
| 238K |
| 256.83M |
| -217.98M |
| 728.18M |
| 678.55M |
Cash Flow
In the last 12 months, operating cash flow was -78.71M and capital expenditures -234K, giving a free cash flow of -78.95M.
| -78.71M |
| -234K |
| -78.95M |
| -1.26 |
Margins
Gross margin is 100%, with operating and profit margins of -10067.25% and -7729.5%.
| 100% |
| -10067.25% |
| -7729.5% |
| -7729.5% |
| -10064.44% |
| -10067.25% |
| -6931.26% |
Dividends & Yields
CGON does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CGON is $65, which is 144.1% higher than the current price. The consensus rating is "Buy".
| $65 |
| 144.1% |
| Buy |
| 9 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 49.39 |
| 2 |